MGMT and glioblastoma: Though widely used, each method has disadvantages with respect to determining methylation cut-off values, tumor content required for evaluation, prognostic accuracy, and financial expense.<h4>Methods</h4>We have developed a method of <i>MGMT</i> classification using artificial intelligence and a large clinicogenomic database of 5841 GBM patients.